AAAAAA
Results:
1-23
|
Results: 23
Authors:
Bax, R
Bywater, R
Cornaglia, G
Goossens, H
Hunter, P
Isham, V
Jarlier, V
Jones, R
Phillips, I
Sahm, D
Senn, S
Struelens, M
Taylor, D
White, A
Citation: R. Bax et al., Surveillance of antimicrobial resistance - what, how and whither?, CL MICRO IN, 7(6), 2001, pp. 316-325
Authors:
Degener, JE
Phillips, I
Citation: Je. Degener et I. Phillips, Comparison of antimicrobial susceptibility test breakpoints of national societies, CL MICRO IN, 7(2), 2001, pp. 51-54
Authors:
Phillips, I
Citation: I. Phillips, Prudent use of antibiotics: Are our expectations justified?, CLIN INF D, 33, 2001, pp. S130-S132
Authors:
Phillips, I
Citation: I. Phillips, Reevaluation of antibiotic breakpoints, CLIN INF D, 33, 2001, pp. S230-S232
Authors:
Zinner, SH
Wise, R
Moellering, RC
Acar, J
Craig, W
Davey, P
Garau, J
Klugman, K
Kristinsson, K
Levin, B
Low, D
MacGowan, A
O'Brien, T
Osterholm, M
Pechere, JC
Phillips, I
Tenover, F
Williams, R
Young, L
Citation: Sh. Zinner et al., Maximizing Antimicrobial Efficacy/Minimizing Antimicrobial Resistance: A Paradigm for the New Millennium - Proceedings of a Symposium held at the American Academy of Arts and Sciences, Cambridge, Massachusetts, 7-8 December 1999 - General discussion, CLIN INF D, 33, 2001, pp. S251-S260
Authors:
King, A
Phillips, I
Citation: A. King et I. Phillips, The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates, J ANTIMICRO, 48(2), 2001, pp. 219-223
Authors:
Raviprakash, K
Marques, E
Ewing, D
Lu, Y
Phillips, I
Porter, KR
Kochel, TJ
August, TJ
Hayes, CG
Murphy, GS
Citation: K. Raviprakash et al., Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF, VIROLOGY, 290(1), 2001, pp. 74-82
Authors:
Finch, R
Beeching, N
Phillips, I
Citation: R. Finch et al., Meeting the challenges in clinical microbiology and infectious diseases, CL MICRO IN, 6(8), 2000, pp. 401-401
Authors:
Bax, R
Gabbay, F
Phillips, I
Citation: R. Bax et al., Antibiotic clinical trials - the Witley Park Symposium Summary (vol 5, pg 774, 1999), CL MICRO IN, 6(6), 2000, pp. 324-324
Authors:
Acar, J
Baquero, F
Geddes, A
Paradisi, F
Phillips, I
Bryskier, A
Low, D
Craig, W
Levy, S
Livermore, D
Roberts, D
Citation: J. Acar et al., Roundtable discussion: Cephalosporins in the 1990s and beyond, CL MICRO IN, 6, 2000, pp. 107-111
Authors:
Baquero, F
Bax, R
Phillips, I
Citation: F. Baquero et al., Antibiotic clinical trials revisited, J ANTIMICRO, 46(5), 2000, pp. 651-652
Authors:
Koeth, LM
King, A
Knight, H
May, J
Miller, LA
Phillips, I
Poupard, JA
Citation: Lm. Koeth et al., Comparison of cation-adjusted Muller-Hinton broth with Iso-Sensitest brothfor the NCCLS broth microdilution method, J ANTIMICRO, 46(3), 2000, pp. 369-376
Authors:
Wise, R
Phillips, I
Citation: R. Wise et I. Phillips, Towards a common susceptibility testing method?, J ANTIMICRO, 45(6), 2000, pp. 919-920
Authors:
King, A
May, J
French, G
Phillips, I
Citation: A. King et al., Comparative in vitro activity of gemifloxacin, J ANTIMICRO, 45, 2000, pp. 1-12
Authors:
Raviprakash, K
Kochel, TJ
Ewing, D
Simmons, M
Phillips, I
Hayes, CG
Porter, KR
Citation: K. Raviprakash et al., Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein, VACCINE, 18(22), 2000, pp. 2426-2434
Authors:
Fattahi, B
Hinn, R
Phillips, I
Wheeler, R
Citation: B. Fattahi et al., What changes do you see in the future of the traditional relationship between oilfield operators and service providers?, J PETRO TEC, 52(3), 2000, pp. 88-88
Authors:
Raviprakash, K
Porter, KR
Kochel, RJ
Ewing, D
Simmons, M
Phillips, I
Murphy, GS
Weiss, WR
Hayes, CG
Citation: K. Raviprakash et al., Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques, J GEN VIROL, 81, 2000, pp. 1659-1667
Authors:
Phillips, I
Citation: I. Phillips, A green greatcoat and a lost poetry - War and Nationalism, spirituality and the impulse towards silence in Thomas MacGreevy, TLS-TIMES L, (5017), 1999, pp. 14-16
Authors:
Phillips, I
Citation: I. Phillips, The use of bacitracin as a growth promoter in animals produces no risk to human health, J ANTIMICRO, 44(6), 1999, pp. 725-728
Authors:
Phillips, I
Citation: I. Phillips, Assessing the evidence that antibiotic growth promoters influence human infections, J HOSP INF, 43(3), 1999, pp. 173-178
Authors:
Stagnitti, F
Li, L
Allinson, G
Phillips, I
Lockington, D
Zeiliguer, A
Allinson, M
Lloyd-Smith, J
Xie, M
Citation: F. Stagnitti et al., A mathematical model for estimating the extent of solute- and water-flux heterogeneity in multiple sample percolation experiments, J HYDROL, 215(1-4), 1999, pp. 59-69
Authors:
King, A
May, J
Phillips, I
Citation: A. King et al., Comparative activity of quinupristin/dalfopristin and RPR 106972 and the effect of medium on in-vitro test results, J ANTIMICRO, 42(6), 1998, pp. 711-719
Authors:
Stagnitti, F
Sherwood, J
Allinson, G
Evans, L
Allinson, M
Li, L
Phillips, I
Citation: F. Stagnitti et al., An investigation of localised soil heterogeneities on solute transport using a multisegment percolation system, NZ J AGR RE, 41(4), 1998, pp. 603-612
Risultati:
1-23
|